These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30555521)

  • 1. Amelioration of hepatic steatosis is associated with modulation of gut microbiota and suppression of hepatic miR-34a in
    Jia N; Lin X; Ma S; Ge S; Mu S; Yang C; Shi S; Gao L; Xu J; Bo T; Zhao J
    Nutr Metab (Lond); 2018; 15():86. PubMed ID: 30555521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats.
    Shen SH; Zhong TY; Peng C; Fang J; Lv B
    BMC Complement Med Ther; 2020 Feb; 20(1):34. PubMed ID: 32024509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Combination of Berberine, Tocotrienols and Coffee Extracts Improves Metabolic Profile and Liver Steatosis by the Modulation of Gut Microbiota and Hepatic miR-122 and miR-34a Expression in Mice.
    Cossiga V; Lembo V; Nigro C; Mirra P; Miele C; D'Argenio V; Leone A; Mazzone G; Veneruso I; Guido M; Beguinot F; Caporaso N; Morisco F
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33924725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gypenosides ameliorate high-fat diet-induced nonalcoholic fatty liver disease in mice by regulating lipid metabolism.
    Zhou T; Cao L; Du Y; Qin L; Lu Y; Zhang Q; He Y; Tan D
    PeerJ; 2023; 11():e15225. PubMed ID: 37065701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypolipidemic effect and gut microbiota regulation of Gypenoside aglycones in rats fed a high-fat diet.
    Xie J; Luo M; Chen Q; Zhang Q; Qin L; Wang Y; Zhao Y; He Y
    J Ethnopharmacol; 2024 Jun; 328():118066. PubMed ID: 38499259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA Mirt2 upregulates USP10 expression to suppress hepatic steatosis by sponging miR-34a-5p.
    Zhang B; Li H; Li D; Sun H; Li M; Hu H
    Gene; 2019 Jun; 700():139-148. PubMed ID: 30898698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.
    Wang P; Wang J; Li D; Ke W; Chen F; Hu X
    J Nutr Biochem; 2020 Jul; 81():108363. PubMed ID: 32388250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
    Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A
    mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of miR-34a in regulating steatosis by targeting PPARα expression in nonalcoholic fatty liver disease.
    Ding J; Li M; Wan X; Jin X; Chen S; Yu C; Li Y
    Sci Rep; 2015 Sep; 5():13729. PubMed ID: 26330104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gypenosides counteract hepatic steatosis and intestinal barrier injury in rats with metabolic associated fatty liver disease by modulating the adenosine monophosphate activated protein kinase and Toll-like receptor 4/nuclear factor kappa B pathways.
    Shen S; Wang K; Zhi Y; Dong Y
    Pharm Biol; 2022 Dec; 60(1):1949-1959. PubMed ID: 36205541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic role of Artemether in the prevention of hepatic steatosis through miR-34a-5p/PPARα pathway.
    Chen L; Yu S; Hong S; Lin X; Zhu X; Cao X; Li Y; Xiao H
    Drug Dev Res; 2023 Apr; 84(2):156-171. PubMed ID: 36541217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of different swimming exercises on alcoholic fatty liver formation in mice].
    Chen R; Chen W; Chen YL; Chen JQ
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2022 Jul; 38(4):341-347. PubMed ID: 36414559
    [No Abstract]   [Full Text] [Related]  

  • 13. Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota.
    Han R; Qiu H; Zhong J; Zheng N; Li B; Hong Y; Ma J; Wu G; Chen L; Sheng L; Li H
    Phytomedicine; 2021 May; 85():153544. PubMed ID: 33773192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gypenosides improve the intestinal microbiota of non-alcoholic fatty liver in mice and alleviate its progression.
    Huang X; Chen W; Yan C; Yang R; Chen Q; Xu H; Huang Y
    Biomed Pharmacother; 2019 Oct; 118():109258. PubMed ID: 31545283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between hepatic miRNA expression, liver triacylglycerols and gut microbiota during metabolic adaptation to high-fat diet in mice.
    Blasco-Baque V; Coupé B; Fabre A; Handgraaf S; Gourdy P; Arnal JF; Courtney M; Schuster-Klein C; Guardiola B; Tercé F; Burcelin R; Serino M
    Diabetologia; 2017 Apr; 60(4):690-700. PubMed ID: 28105518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kefir alleviates obesity and hepatic steatosis in high-fat diet-fed mice by modulation of gut microbiota and mycobiota: targeted and untargeted community analysis with correlation of biomarkers.
    Kim DH; Kim H; Jeong D; Kang IB; Chon JW; Kim HS; Song KY; Seo KH
    J Nutr Biochem; 2017 Jun; 44():35-43. PubMed ID: 28384519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of the Caspases 1/11 Modulates Liver Global Lipid Profile and Gut Microbiota in High-Fat-Diet-Induced Obese Mice.
    de Sant'Ana LP; Ribeiro DJS; Martins AMA; Dos Santos FN; Corrêa R; Almeida RDN; Eberlin MN; Maurice CF; Magalhães KG
    Front Immunol; 2019; 10():2926. PubMed ID: 31998283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cadmium chloride induces non-alcoholic fatty liver disease in rats by stimulating miR-34a/SIRT1/FXR/p53 axis.
    Alshehri AS; El-Kott AF; El-Kenawy AE; Khalifa HS; AlRamlawy AM
    Sci Total Environ; 2021 Aug; 784():147182. PubMed ID: 34088068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the fecal microbiome and metabolome by resistant dextrin ameliorates hepatic steatosis and mitochondrial abnormalities in mice.
    Zhang Z; Chen X; Cui B
    Food Funct; 2021 May; 12(10):4504-4518. PubMed ID: 33885128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.